{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:42:06Z","timestamp":1760370126839,"version":"3.41.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["IN 00023001"],"award-info":[{"award-number":["IN 00023001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11085-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:10:50Z","timestamp":1752577850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure"],"prefix":"10.1038","volume":"15","author":[{"given":"V.","family":"Pitova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Frankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Holinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Merta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vesela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Hubacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jirsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sperl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"11085_CR1","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. Electronic address, E. E. E., Clinical Practice Guidelines Panel & representative, C. E. G. B. & Panel, M. EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol. 73, 1170\u20131218 (2020). https:\/\/doi.org\/10.1016\/j.jhep.2020.08.018","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"11085_CR2","doi-asserted-by":"publisher","unstructured":"Younossi, Z. M. et al. Long-term benefits of sustained virologic response for patient-reported outcomes in patients With chronic hepatitis C virus infection. Clin. Gastroenterol. Hepatol. 18, 468\u2013476 e411 (2020). https:\/\/doi.org\/10.1016\/j.cgh.2019.07.047","DOI":"10.1016\/j.cgh.2019.07.047"},{"key":"11085_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11904-019-00466-1","volume":"16","author":"A Mohanty","year":"2019","unstructured":"Mohanty, A., Salameh, S. & Butt, A. A. Impact of direct acting antiviral agent therapy upon extrahepatic manifestations of hepatitis C virus infection. Curr. HIV\/AIDS Rep. 16, 389\u2013394. https:\/\/doi.org\/10.1007\/s11904-019-00466-1 (2019).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"11085_CR4","doi-asserted-by":"publisher","unstructured":"Schlevogt, B. et al. Weight gain after interferon-free treatment of chronic hepatitis C-Results from the German hepatitis C-Registry (DHC-R). Biomedicines 9. https:\/\/doi.org\/10.3390\/biomedicines9101495 (2021).","DOI":"10.3390\/biomedicines9101495"},{"key":"11085_CR5","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s11606-020-05782-6","volume":"35","author":"A Do","year":"2020","unstructured":"Do, A. et al. Excess weight gain after cure of hepatitis C infection with Direct-Acting antivirals. J. Gen. Intern. Med. 35, 2025\u20132034. https:\/\/doi.org\/10.1007\/s11606-020-05782-6 (2020).","journal-title":"J. Gen. Intern. Med."},{"key":"11085_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.5152\/tjg.2019.18514","volume":"30","author":"M El Kassas","year":"2019","unstructured":"El Kassas, M. et al. A significant upsurge of body mass index in patients with chronic hepatitis C successfully treated with direct-acting antiviral regimens. Turk. J. Gastroenterol. 30, 708\u2013713. https:\/\/doi.org\/10.5152\/tjg.2019.18514 (2019).","journal-title":"Turk. J. Gastroenterol."},{"key":"11085_CR7","doi-asserted-by":"publisher","unstructured":"Chen, C. H. et al. Weight gain and increased body mass index in patients with hepatitis C after eradication using direct-acting antiviral therapy in Taiwan. Diagnostics (Basel) 14. https:\/\/doi.org\/10.3390\/diagnostics14020213 (2024).","DOI":"10.3390\/diagnostics14020213"},{"key":"11085_CR8","doi-asserted-by":"publisher","first-page":"135965352211152","DOI":"10.1177\/13596535221115253","volume":"27","author":"CL Nkwocha","year":"2022","unstructured":"Nkwocha, C. L., Carter, P. S., Blair, S., Blackwell, J. M. & Fasanmi, E. O. Understanding the effect of direct-acting antiviral therapy on weight in patients with chronic hepatitis C. Antivir Ther. 27, 13596535221115253. https:\/\/doi.org\/10.1177\/13596535221115253 (2022).","journal-title":"Antivir Ther."},{"key":"11085_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465. https:\/\/doi.org\/10.1038\/ng.257 (2008).","journal-title":"Nat. Genet."},{"key":"11085_CR10","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1172\/JCI65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 122, 4130\u20134144. https:\/\/doi.org\/10.1172\/JCI65179 (2012).","journal-title":"J. Clin. Invest."},{"key":"11085_CR11","doi-asserted-by":"publisher","unstructured":"Tardelli, M. et al. Absence of adiponutrin (PNPLA3) and monoacylglycerol lipase synergistically increases weight gain and aggravates steatohepatitis in mice. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22042126 (2021).","DOI":"10.3390\/ijms22042126"},{"key":"11085_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s42255-019-0066-3","volume":"1","author":"A Yang","year":"2019","unstructured":"Yang, A., Mottillo, E. P., Mladenovic-Lucas, L., Zhou, L. & Granneman, J. G. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes. Nat. Metab. 1, 560\u2013569. https:\/\/doi.org\/10.1038\/s42255-019-0066-3 (2019).","journal-title":"Nat. Metab."},{"key":"11085_CR13","doi-asserted-by":"publisher","unstructured":"Cinque, F. et al. Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown. Nutrients 14. https:\/\/doi.org\/10.3390\/nu14030556 (2022).","DOI":"10.3390\/nu14030556"},{"key":"11085_CR14","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1194\/jlr.M600185-JLR200","volume":"47","author":"PA Wilson","year":"2006","unstructured":"Wilson, P. A., Gardner, S. D., Lambie, N. M., Commans, S. A. & Crowther, D. J. Characterization of the human patatin-like phospholipase family. J. Lipid Res. 47, 1940\u20131949. https:\/\/doi.org\/10.1194\/jlr.M600185-JLR200 (2006).","journal-title":"J. Lipid Res."},{"key":"11085_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/liv.13222","volume":"37","author":"V Wieser","year":"2017","unstructured":"Wieser, V. et al. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression. Liver Int. 37, 299\u2013306. https:\/\/doi.org\/10.1111\/liv.13222 (2017).","journal-title":"Liver Int."},{"key":"11085_CR16","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1073\/pnas.1003585107","volume":"107","author":"Y Huang","year":"2010","unstructured":"Huang, Y. et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc. Natl. Acad. Sci. U S A. 107, 7892\u20137897. https:\/\/doi.org\/10.1073\/pnas.1003585107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"11085_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","volume":"73","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J. Hepatol. 73, 263\u2013276. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.006 (2020).","journal-title":"J. Hepatol."},{"key":"11085_CR18","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","volume":"92","author":"JN Davis","year":"2010","unstructured":"Davis, J. N. et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am. J. Clin. Nutr. 92, 1522\u20131527. https:\/\/doi.org\/10.3945\/ajcn.2010.30185 (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"11085_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.atherosclerosis.2010.04.007","volume":"211","author":"R Cifkova","year":"2010","unstructured":"Cifkova, R. et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007\/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 211, 676\u2013681. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.04.007 (2010).","journal-title":"Atherosclerosis"},{"key":"11085_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000441185","volume":"93","author":"M Krawczyk","year":"2016","unstructured":"Krawczyk, M., Stachowska, E., Milkiewicz, P., Lammert, F. & Milkiewicz, M. Reduction of caloric intake might override the prosteatotic effects of the PNPLA3 p.I148M and TM6SF2 p.E167K variants in patients with fatty liver: Ultrasound-Based prospective study. Digestion 93, 139\u2013148. https:\/\/doi.org\/10.1159\/000441185 (2016).","journal-title":"Digestion"},{"key":"11085_CR21","doi-asserted-by":"publisher","unstructured":"Frankova, S., Uzlova, N., Merta, D., Pitova, V. & Sperl, J. Predictors of significant liver fibrosis in people with chronic hepatitis C who inject drugs in the Czech Republic. Life (Basel) 13. https:\/\/doi.org\/10.3390\/life13040932 (2023).","DOI":"10.3390\/life13040932"},{"key":"11085_CR22","unstructured":"LSM by VCTE\u2122 Interpretation Guide. https:\/\/www.echosens.com\/wp-content\/uploads\/2021\/01\/Interpretation-Guide-2020.pdf (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11085-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11085-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:10:51Z","timestamp":1752577851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11085-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11085"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11085-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Institute for Clinical and Experimental Medicine and the Thomayer University Hospital, Prague, Czech Republic, study approval number 29,444\/21; G-21-72. It was carried out in accordance with the Declaration of Helsinki. All study participants gave written informed consent to the participation in the study and to the storage of blood samples and agreed to use the blood for genetic testing. Written consent was obtained before being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"25543"}}